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ABSTRACT 
Nongenomic Effects of Estrogens on Epithelial Chloride Secretion 
by 
Sabyasachi Moulik 
 
The human colonic cell line T84, a model for studying epithelial chloride secretion and cystic 
fibrosis chloride channel (CFTR) function, was used to investigate the regulatory role of 
estrogens in transepithelial ion transport. Estrogens and other steroid hormones do not stimulate 
chloride secretion by themselves. However, 17 β-estradiol (17β-E2) rapidly (within seconds to 
minutes) potentiates carbachol- and thapsigargin-stimulated chloride secretion measured as short 
circuit current in voltage-clamped T84 monolayer cultures. The cholinergic agonist carbachol 
and the SR Ca2+ ATPase inhibitor thapsigargin stimulate chloride secretion by elevating 
intracellular calcium. 17 α-estradiol, a stereoisomer that does not activate nuclear estrogen 
receptors, is equipotent with 17β-E2. Other non-estrogen steroids produce much less, if any, 
potentiation of calcium-stimulated chloride secretion. The estrogen receptor antagonist 
tamoxifen does not block 17β-E2 potentiation of calcium-stimulated chloride secretion, 
indicating that the classical nuclear estrogen receptors are not involved. Potentiation is greater 
when 17β-E2 is applied to the apical membrane than to the basolateral membrane. 17β-E2 effects 
on chloride secretion coincide with an increase in monolayer electrical conductance, which is 
consistent with activation of one or more ion channel species. Potentiation is not blocked by the 
chloride channel blockers DIDS and NPPB but is abolished by the PKA inhibitor H89, 
suggesting that 17β-E2 potentiation depends on the activity of CFTR but not other types of 
apical membrane chloride channels. 17β-E2 does not increase the activity of calcium-activated 
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potassium channels in the basolateral membrane as measured in nystatin-permeabilized 
monolayers. 17β-E2 effects are not blocked by the MAP kinase kinase inhibitor PD 98059 or by 
the PKC inhibitor bisindoylmaleamide, suggesting that these signal transduction pathways are 
not involved. 17β-E2 potentiation requires extracellular Ca2+. Paradoxically, 17β-E2 reduces the 
rise in intracellular free Ca2+ levels in thapsigargin-stimulated T84 cells, as measured by fura-2 
fluorescence. From my studies I conclude that 17β-E2 causes an increase in the sensitivity of 
T84 cells to calcium-elevating secretagogues. This effect may be due to nongenomic actions of 
17β-E2 on CFTR function and/or the activity of store-operated calcium channels that leads to a 
change in CFTR functional regulation.  
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CHAPTER 1 
INTRODUCTION 
 
Steroid Hormone Action 
 
Steroid hormones are lipophilic, low-molecular weight compounds synthesized from 
cholesterol. These hormones mediate a wide variety of vital physiological functions ranging 
from acting as anti-inflammatory agents to regulating events during pregnancy. Steroid 
hormones are synthesized mainly by endocrine glands such as the gonads (testis and ovary), the 
adrenals, and (during gestation) by the fetoplacental unit and are then released into the blood 
circulation. They can be grouped into one of three classes: the sex steroids, the adrenal steroids, 
and vitamin D3 (Evans 1988). The sex steroids (estrogens, progesterone, and testosterone), 
influence the sexual differentiation of the genitalia, determine secondary sexual characteristics 
during development and sexual maturation, contribute to the maintenance of their functional 
state in adulthood, and control or modulate sexual behaviour. The principal adrenal steroids are 
the mineralocorticoids and glucocorticoids. The important mineralocorticoid, aldosterone, 
participates in potassium excretion and sodium reabsorption. Cortisol, the major adrenal 
glucocorticoid in humans, stimulates conversion of proteins to carbohydrates, raises blood sugar 
levels, and promotes glycogen storage in the liver. The adrenal cortex secretes androgenic 
hormones androstenedione, testosterone, and dehydroepiandrosterone. The adrenal androgen 
dehydroepiandrosterone is the primary source of androgen in women. Vitamin D3 plays an 
important role in calcium and phosphate regulation.  
The classic pathway for steroid hormone action involves binding of hormone to specific 
intracellular receptors. The receptor-steroid complex interacts with hormone-responsive elements 
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within target genes, and initiates new transcription and protein synthesis. The resulting new 
proteins influence various cellular functions. Genomic steroid effects are characterized by 
delayed onset of action (hours) and sensitivity to blockers of transcription (e.g. actinomycin D) 
and protein synthesis (e.g. cycloheximide). Over the past decade, there has been increasing 
evidence of rapid (seconds to minutes) nongenomic effects of steroids, which are initiated at the 
plasma membrane and result in the activation of intracellular second messenger pathways 
(Schmidt and others 2000; Harvey and others 2001). Examples of nongenomic effects of steroids 
include rapid aldosterone effects on lymphocytes, renal cells and vascular smooth muscle cells 
( Koppel and others 2003; Boldyreff and Wehling 2004; Uhrenholt and others 2004); vitamin D3 
effects on osteoblasts (Erben and others 2002); progesterone action on primate coronary arteries 
(Minshall and others 2002); and  estrogen action on neurons (Abraham and others 2004), and 
vascular smooth muscle cells (Mendelsohn 2002a). The rapid nongenomic steroid signaling is 
characterized by several of the following criteria: 1) responses occur within seconds to minutes, 
actions too rapid to be compatible with RNA and protein synthesis; 2) responses refractory to 
inhibitors of transcription and translation; and 3) responses can be initiated by steroids 
conjugated to macromolecules (e.g. bovine serum albumin) that are too large to enter cells. 
 
Estrogens and Estrogen Receptors 
Estrogens are sex steroids that exist mainly in three molecular forms: estradiol, estrone, 
and estriol. In premenopausal women, most of the circulating estrone is derived from estradiol. 
In postmenopausal women estrone is the predominant plasma estrogen and is derived from the 
conversion of androcortical androstenedione in the liver. Estriol is formed in the liver as a 
conversion product of estradiol and estrone. The biological potency of estradiol is much higher 
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than the other molecular forms, and hence estradiol is physiologically the most important 
estrogen.  
For many years it was thought that only a single form of the nuclear estrogen receptor, 
ERα, existed (Greene and others 1984). More recently, multiple laboratories independently 
reported discovery of a second estrogen receptor (ERβ) in rat (Kuiper and others 1996), mouse 
(Tremblay and others 1997), and human (Mosselman and others 1996). Of the classical estrogen 
receptors (ERα and ERβ), ERα is the predominant receptor in most target organs (Lubahn and 
others 1993). These two receptors are not isoforms of a single receptor gene but reside on 
different chromosomes (ERβ is localized on human chromosome 14, and ERα is localized on 
chromosome 6) and are distinct proteins (Enmark and others 1997). 
The ERα and ERβ receptors belong to the steroid/ thyroid nuclear receptor superfamily 
(Figure 1), members of which share a common structure characterized by the N-terminal A/B 
domain, the DNA-binding C domain and the ligand-binding D/E/F domain (Tsai and O'Malley 
1994; Mangelsdorf and others 1995; Robinson-Rechavi and others 2003). In the absence of 
ligand, estrogen receptors are bound to several proteins in the nucleus, such as the heat shock 
proteins, to form a complex (Pratt and Toft 1997). After estrogen binding, a conformational 
change occurs in the receptor structure that triggers the dissociation of the heterocomplex, 
dimerization of liganded receptors, interaction between receptor and specific DNA sequences, 
recruitment of co-activators, or other transcription factors and formation of a preinitiation 
complex in target genes (Nilsson and others 2001).  
The N-terminal domain of ERα and ERβ contains a ligand-independent transcriptional 
activation function, the AF-1 (Kraus and others 1995; McInerney and Katzenellenbogen 1996). 
This region is involved in protein-protein interaction and transcription activation (McInerney and 
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others 1996; Onate and others 1998). Using an estrogen response element based reporter 
construct, it is seen that the activity of AF-1 in ERα is many times greater than in ERβ (Cowley 
and Parker 1999).  
 
 
 
Figure 1  Diagramatic Representation of the Domain Structure of  Nuclear Receptors. The A/B 
domain at the N terminus contains the AF-1 site where other transcription factors interact. The 
C/D domain contains the two-zinc finger structure that binds to DNA, and the C/F domain 
contains the ligand binding pocket as well as the AF-2 domain (Nilsson and others 2001). 
 
 
The DNA-binding domain is highly conserved in the steroid/thyroid nuclear receptor 
superfamily containing two zinc fingers that are important for receptor dimerization and DNA 
binding (Franco and others 2003; Meza and others 2003). The DNA binding domains of ERα 
and ERβ are highly homologous. The P box, a sequence that is critical for target-DNA 
recognition and specificity, is identical in both receptors (Vanacker and others 1999). Thus ERα 
and ERβ bind to various estrogen response elements with similar specificity and affinity. The D 
region of the ligand-binding domain serves as a linker between the DNA-binding domain and the 
ligand-binding domain. The E/F region of the ligand-binding domain participates in ligand 
binding, nuclear localization, receptor dimerization, and transcriptional regulation (Tsai and 
O'Malley 1994; Horwitz and others 1996). ERα and ERβ have similar binding affinities for 17 β-
estradiol, with Kd values of 0.2 and 0.6 nM, respectively (Kuiper and others 1996). The ligand-
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binding domain also contains a second transcriptional activation function, AF-2 that differs from 
AF-1 in that AF-2 activity is ligand-dependent (Webster and others 1988).  
There is striking difference between the two receptors in their response to selective 
estrogen receptor modulators (SERMs) like tamoxifen, raloxifene, and pure antiestrogens like 
ICI 164384 (Lonard and Smith 2002). One mechanism by which these compounds inhibit 
estrogen receptor action is by competition with 17 β-estradiol for binding to the estrogen 
receptor. It is thought that SERMs and antiestrogens promote a conformational change different 
from that induced by 17 β-estradiol (Beekman and others 1993; McDonnell 1999). SERMs, like 
tamoxifen, have agonistic activity in certain cells, such as chicken embryo fibroblasts (Berry and 
others 1990) and MDA-231 human breast cancer cells (Montano and others 1995). Tamoxifen 
can show some agonistic activity with ERα but exhibits no agonistic activity with ERβ 
(McInerney and others 1998). The cell and promoter dependence of tamoxifen agonism has been 
attributed to the cell and promoter specificity of AF-1 activity (Berry and others 1990; Metzger 
and others 1992; Tzukerman and others 1994). The activity of AF-1 is many times more in ERα 
than in ERβ (Cowley and Parker 1999). This explains the agonistic activity of tamoxifen in cells 
containing pure ERα. Pure antagonists like ICI 164384 act by promoting rapid degradation of 
estrogen receptors (Dauvois and others 1992). 
 
Nongenomic Action of Estrogens 
Many tissues traditionally considered non-targets for classical estrogen action are now 
known to be regulated by nongenomic mechanisms. In the cardiovascular and central nervous 
system, estrogen induces rapid vasodilatation (Mendelsohn 2002a; Mendelsohn 2002b) and  
neuronal excitability in the cerebellum, cerebral cortex, and the pyramidal neurons of the 
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hippocampus (McEwen and Alves 1999). Increases in cAMP in response to estrogen in vascular 
smooth muscle cells (Farhat and others 1996a; Farhat and others 1996b), breast cancer cells, and 
uterine cells (Aronica and others 1994) are caused by a nongenomic mechanism. In primary 
cultured rabbit kidney proximal tubule cells 17 β-estradiol-BSA conjugate rapidly stimulates 
Ca2+ uptake, which is mediated by cAMP and PKC pathways (Han and others 2000). 17 β-
estradiol can also rapidly activate extracellular-regulated kinases (Erk1/Erk2) in breast cancer 
cells (Improta-Brears and others 1999; Fernando and Wimalasena 2004). Recent reviews have 
focused on the nongenomic actions of estrogen (Coleman and Smith 2001; Simoncini and 
Genazzani 2003).  
Nongenomic actions of estrogens are often associated with cell membrane receptors such 
as G protein coupled receptors in osteoblasts (Le Mellay and others 1997) and cell membrane ion 
channels in vascular smooth muscle cells (White and others 1995). Many of the membrane-
delimited estrogen responses are mediated by the activation of phospholipase C/adenylyl cyclase 
pathways via the modulation of G protein-coupled receptors (Kelly and others 1999).  There is 
increasing evidence that rapid effects of 17 β-estradiol occurs after the sex steroid binds to a 
plasma membrane estrogen receptor. Plasma membrane receptors have been demonstrated by 
immunohistochemistry (Russell and others 2000) and immunoblotting (Chambliss and others 
2000) of isolated plasma membrane domains. Membrane estrogen receptors that are structurally 
related or identical to the classical estrogen receptors have been localized in several cell types 
such as pituitary tumor cells (Monje and Boland 1999; Watson and others 1999) and Chinese 
hamster ovary cells (Razandi and others 1999). The membrane and classical estrogen receptors 
originate from a single transcript and have near-identical affinities for 17 β-estradiol (Razandi 
and others 1999). Membrane estrogen receptors have been detected in GH3/B6 rat pituitary 
 20
tumor cells by directing antibodies against epitopes of the classical estrogen receptors (Pappas 
and others 1995). In the distal colonic crypts of female rats and female human, membrane-
associated ERα and ERβ was observed (Doolan and others 2000b). In many cell types membrane 
estrogen receptors can activate the α subunit of GTP-binding proteins leading to downstream 
signal transduction (Levin 1999). 
The rapid effects of estrogen in many cells have been attributed to a population of 
membrane estrogen receptors (Figure 2) embedded in caveolar rafts and other plasma membrane 
domains (Kim and others 1999; Chambliss and others 2000; Razandi and others 2002). Caveolae 
are small (50-100 nm diameter) flask-shaped subcompartments of the plasma membranes. 
Caveolae are structurally composed of a family of proteins, known as caveolins. Caveolin 1 and 
2 are found in many cells expressing caveolae (Anderson 1998). Caveolin 1 contains a cytosolic, 
N-terminal scaffolding domain that binds to signaling molecules and inhibits their usual 
activation after growth factor ligation of receptors (Okamoto and others 1998). Within the 
caveolae, an estrogen receptor interaction with other signaling molecules may be important for 
the propagation of signal transduction. There is also evidence of a plasma membrane protein  
called the steroid hormone recognition and effector complex that actively mediates rapid, 
nongenomic responses to steroids (Daufeldt and others 2003). 
 
Rapid Effects of Aldosterone and Estrogen on Colonic Epithelium 
A major target for aldosterone action is the mammalian distal colon. The Na+/H+ 
exchanger in the basolateral cell membrane of the colonic epithelia is the primary ion transport 
target of the nongenomic actions of aldosterone (Harvey and others 2001). In the human and rat 
distal colon, recent studies have demonstrated rapid nongenomic activation of Na+/H+ exchange,  
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Figure 2  Schemes of Signal Transduction Resulting from Liganding of the Membrane Estrogen 
Receptor by Estrogen. The membrane ER activates the α subunit of several GTP-binding 
proteins and this leads to downstream signal transduction, as shown. Membrane ER can also 
modulate JNK (not shown). The dashed line indicates that DAG indirectly leads to PKC 
activation. Abbreviations: Cai2+, intracellular Ca2+; DAG, diaclglycerol; E2, estradiol; ER, 
estrogen receptor; ERK, extracellular-signal-regulated protein kinase; Gαs/Gαq, G proteins; 
Ins(1,4,5)P3, inositol (1,4,5) trisphosphate; JNK, Jun kinase; PKA, protein kinase A; PKC, 
protein kinase C; PLC, phospholipase C (Levin 1999). 
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K+ recycling, and PKC activity by aldosterone (Doolan and Harvey 1996; Doolan and others 
1998; Maguire and others 1999).  The physiological function of nongenomic effects of 
aldosterone is to shift the balance from net secretion to net absorption in colonic epithelia  
(Harvey and others 2001; Harvey and others 2002). 
The presence of estrogen receptors in the colon suggests that the colon is also a target for 
estrogen action (Thomas and others 1993). By examining the estrous-cycle-related changes in 
the epithelium, significant variations in both the distribution of epithelial cells through the cell 
cycle as well as the number of epithelial cells per unit area in mouse jejunal and colonic 
epithelium has been found (Cheng and Bjerknes 1988). A role of estrogens in stimulating the 
proliferation of colonic epithelial cells has been postulated (Cheng and Bjerknes 1988).  It has 
also been reported that under selected conditions, growth of colonic cell line, Caco-2, is triggered 
by 17 β-estradiol (Di Domenico and others 1996). Cell growth is estradiol concentration 
dependent and prevented by tamoxifen and the pure antagonist, ICI 182780 (Di Domenico and 
others 1996).  
 There is increasing evidence of nongenomic effects of estrogen on the gastrointestinal 
system. Forskolin stimulates Cl¯ secretion in rat distal colon by a cAMP dependent activation of 
apical CFTR Cl¯ channels (Schultheiss and others 1998). A physiological concentration of 17 β-
estradiol rapidly reduces the forskolin (20 µM) stimulation of Cl¯ secretion (Condliffe and others 
2001) in the distal colon of female rats. This effect can be seen after preincubating distal colonic 
epithelial sheets with 17 β-estradiol for only 10 minutes, and the inhibition of Cl¯  secretion is not 
blunted by tamoxifen (Condliffe and others 2001). The presence of  17 α-estradiol (100 nM), a 
stereoisomer that does not activate nuclear estrogen receptors, does not cause inhibition of 
forskolin-stimulated Cl¯ secretion (Condliffe and others 2001). The intracellular Ca2+  chelator 
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BAPTA (50 µM) or the PKC inhibitor chelerythrine chloride (1 µM) abolishes the antisecretory 
rapid effects of 17 β-estradiol on forskolin-stimulated Cl¯  secretion (Condliffe and others 2001). 
Additionally, in the rat distal colonic epithelium, a brief incubation of distal colonic epithelial 
sheets with 10-100 nM concentration of 17 β-estradiol also significantly reduces the Cl¯ secretory 
responses to Ca2+ dependent secretagogue carbachol (10 µM) (Condliffe and others 2001).    
17 β-estradiol rapidly increases the activity of cAMP dependent protein kinase (PKA), 
stimulates a rise in intracellular Ca2+ ( Doolan and others 2000a), activates protein kinase C  
(Doolan and Harvey 1996; Doolan and others 2000a; Harvey and others 2002), increases 
intracellular alkalinization, and decreases K+ channel activity in colonic epithelium ( McNamara 
and others 2000; Condliffe and others 2001). All these rapid signaling responses seen in native 
colonic epithelial sheets are sex-steroid specific and female gender specific and observed in the 
low nanomolar (nM) concentrations of 17 β-estradiol (Harvey and others 2002). 
 In the colonic epithelial cell line T84, micromolar (µM) concentrations of 17 β-estradiol 
caused a rapid and reversible inhibition of forskolin-stimulated Cl¯ secretion (Singh and others 
2000). Singh and others (2000) also reported that 17 α-estradiol, the stereoisomer that failed to 
bind and activate nuclear estrogen receptors was equipotent with 17 β-estradiol, suggesting a 
nongenomic mechanism of steroid action. Tamoxifen and synthetic estrogens including 
diethylstilbesterol also inhibited forskolin-stimulated Cl¯ secretion. Diethylstilbesterol and other 
synthetic estrogens inhibited CFTR chloride channel activity in excised membrane patches. 
Additionally, experiments with radioactive photoactivatable estrogen derivatives demonstrated 
that these compounds bind directly to CFTR expressed in Sf9 cells by gene transfection. Singh 
and others (2000) concluded that estrogens can  interact directly with CFTR by a nongenomic 
mechanism to inhibit channel activity and anion transport. 
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Chloride Secretion in the Colon 
 The main functions of the mammalian intestine are nutrient absorption, and regulation of 
water and electrolyte balance. The villous and surface epithelial cells are responsible for 
absorption, whereas the intestinal crypts are the main location of secretory epithelial cells (Welsh 
and others 1982). In the healthy state, the mammalian colon is primarily an absorptive organ 
with water, sodium, and chloride being absorbed while potassium and bicarbonate are secreted 
(Liedtke 1989). However, in the case of secretory diarrhea, the colon is altered from an 
absorptive to a secretory state. 
The mechanism for epithelial Cl¯ secretion occurs was initially proposed in the late 
seventies (Frizzell and others 1979). For Cl¯ secretion to occur, a favorable electrochemical 
gradient must exist (Figure 3). Cl¯ is taken up from the bloodstream across the basolateral 
membrane of epithelial cells via bumetanide-sensitive Na+/2Cl¯/K+ co-transporter. This co-
transporter is driven by low intracellular Na+ concentration established by the active Na+/K+ 
ATPase localized at the basolateral membrane. This allows Cl¯  to accumulate in the cell cytosol 
above its electrochemical equilibrium. When apical chloride channels are opened, Cl¯ flows out 
of the cell down this electrochemical gradient, resulting in overall net transepithelial transfer of 
the anion. Cl¯   exit occurs predominantly through the apical cAMP activated CFTR (cystic 
fibrosis transmembrane conductance regulator) Cl¯ channels. The presence of basolateral K+ 
channels serve to recycle co-transported K+ back across the basolateral membrane, thus 
preventing cell depolarization (Barrett 2000). Electroneutral NaCl absorption (parallel Na+/H+ 
and Cl¯/HCO3¯ exchange) dominates in the surface epithelium and is also present in the crypts. 
Electrogenic Na+ absorption via the epithelial Na+ channel (ENaC) takes place in the surface 
epithelium and upper crypts of the distal colon. The cystic fibrosis transmembrane conductance 
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regulator (CFTR) is expressed throughout the colonic epithelium and dominates in the crypts. Cl¯ 
secretion is activated by stimulation of CFTR (Kunzelmann and Mall 2002). 
 
 
 
 
 
 
 
 
 
 
Figure 3  Cellular Model for Cl¯ Secretion. Cl¯ secretion is activated by cAMP-dependent 
stimulation of CFTR Cl¯ channels, which are the predominant apical Cl¯ channels in the native 
colon. Cl¯ secretion is paralleled by secretion of K+ via apical K+ channels and Na+ transport 
through the paracellular shunt. Cl¯ is taken up into the cells by the basolateral Na+/2Cl¯/K+. The 
rate of secretion is controlled by the activity of Na+/2Cl¯/K+, which is regulated through the 
intracellular Cl¯ concentration, cell swelling, and probably phosphorylation. Cl¯ transport is 
maintained by basolateral cAMP-activated KVLQT1/KCNE3 and Ca2+-activated SK4 K+ 
channels (Kunzelmann and Mall 2002). 
 
The human epithelial cell line T84 is a well-established model for epithelial chloride 
transport (Dharmsathaphorn and others 1984). These cells can be grown on semipermeable 
supports to form polarized monolayers that develop high levels of transepithelial resistance 
similar to native colonic epithelium. T84 monolayers grown on semipermeable supports can be 
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mounted in Ussing chambers (named after Hans Ussing, and initially designed to study vectorial 
ion transport through the frog skin (Ussing and Zerahn 1951)) and used for electrophysiological 
studies. T84 monolayers mounted in Ussing chambers develop a spontaneous potential 
difference and current that can be short-circuited (Dharmsathaphorn and others 1985). The short-
circuit current (ISC) is defined as the current that must be passed across the epithelial monolayer 
to reduce the transepithelial voltage to 0 mV.  
 At the apical side of the T84 cell, chloride conductance is dominated by CFTR, the 
cAMP-activated chloride channel. The transport systems localized in the basolateral membrane 
are: 1) a ouabain-inhibitable Na+/K+ ATPase, which catalyzes the ATP-driven uptake of 2K+ and 
efflux of 3Na+ 2) a bumetanide-inhibitable Na+/2Cl+/K+ co-transporter driven by low 
intracellular Na+ concentration established by Na+/K+ ATPase, allowing chloride to accumulate 
in the cell cytosol above its electrochemical equilibrium  3) a cAMP-stimulated, Ba2+-inhibitable 
K+ channel, and 4) a Ca2+-activated K+ channel. 
 The epithelial cell line T84 secretes chloride ions in response to both cAMP- and 
Ca2+-regulated pathways (Barrett 1993; MacVinish and others 1993). Forskolin stimulates Cl¯ 
secretion in T84 cells by elevating intracellular cAMP, which leads to  activation of protein 
kinase A (Riordan 1993). This causes the dissociation of protein kinase A catalytic subunit from 
its regulatory subunit. The catalytic subunit of protein kinase A phosphorylates the apical CFTR 
Cl¯ channels, activating them, leading to Cl¯ secretion. The Ca2+ ATPase inhibitor thapsigargin 
and the cholinergic agonist carbachol stimulate Cl¯ secretion in T84 cells by raising intracellular 
calcium. Thapsigargin raises intracellular calcium by inhibiting Ca2+ATPase of the endoplasmic 
reticulum. Carbachol binds to a basolateral G protein-linked muscarinic receptor and thereby 
activates phospholipase C. Phospholipase C acts on phosphatidylinositol bisphosphate (PIP2) to 
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yield calcium-mobilizing messenger inositol trisphosphate [Ins(1,4,5)P3] and diacylglycerol 
(DAG). Elevation in intracellular calcium opens basolateral K+ channels providing the driving 
force for Cl¯ exit through the small population of constitutively active apical CFTR Cl¯ channels. 
Cyclic nucleotides (cAMP or cGMP) evoke a sustained increase in Cl¯ secretion, whereas the 
calcium- dependent Cl¯ secretion is considerably more transient due to negative regulation 
exerted by mediators like epidermal growth factor, protein kinase C and inositol 
tetrakisphosphate [Ins(3,4,5,6)P4] (Barrett 1993; Barrett 1997).  
 
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 
 CFTR is a low-conductance chloride channel that is activated by phosphorylation and 
gated by ATP binding and hydrolysis. The structure of CFTR resembles other ATP-binding 
cassette (ABC) transporters. They have two membrane domains, each consisting of six 
transmembrane segments and two nucleotide-binding domains. CFTR activity is controlled by a 
central regulatory domain of approximately 200 amino acids (Gadsby and Nairn 1999; Schultz 
and others 1999). The regulatory domain contains multiple consensus phosphorylation sites for 
cAMP-dependent protein kinase (PKA), protein kinase C (PKC), and Type II cGMP-dependent 
protein kinase (Riordan and others 1989; Riordan 1993; Gadsby and Nairn 1999; Sheppard and 
Welsh 1999). The more extensive the phosphorylation, the greater the channel open probability 
of CFTR (Hwang and others 1993; Gadsby and Nairn 1999). There appears to be extensive 
redundancy in the regulatory PKA phosphorylation sites. Five sites are phosphorylated in vivo, 
but removal of these sites or all 10 dibasic PKA sites reduced but did not eliminate PKA 
activation (Chang and others 1993). CFTR is still phosphorylated after removal of the 10 dibasic 
sites indicating that phosphorylation at non-dibasic PKA sites is sufficient for channel activation 
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(Riordan 1993; Gadsby and Nairn 1999; Sheppard and Welsh 1999). PKC phosphorylation may 
be required for activation by PKA (Jia and others 1997). Following phosphorylation, opening and 
closing of the channel is controlled by ATP binding and hydrolysis and CFTR is deactivated by 
protein phosphatases (Riordan 1993; Gadsby and Nairn 1999; Sheppard and Welsh 1999). 
  Recently, the crystallisation of wild-type human CFTR has been accomplished 
(Rosenberg and others 2004). Rosenberg and others (2004) have reported the formation of two-
dimensional crystalline arrays of CFTR in the presence of the high affinity ligand, AMP-PMP. 
Electron crystallography, yielding 3D structural information to a resolution of ~ 2 nm indicated 
that the crystallized CFTR is monomeric, has overall structural similarities to P-glycoprotein, 
and can assume two different conformational states, possibly reflecting differential nucleotide 
binding to the two nucleotide binding domains (Rosenberg and others 2004). 
 
Rationale for this Investigation 
It has been suggested that 17 β-estradiol may alter colonic ion transport during high 
estrogen states like pregnancy and certain phases of menstrual cycle (Condliffe and others 2001). 
These effects might involve rapid, nongenomic actions of 17 β-estradiol. Most studies involving 
rapid effects of estrogens on epithelial Cl¯ secretion have been done on native colonic epithelial 
sheets. Studies of electrogenic Cl¯ secretion across sheets of native colonic epithelia cannot 
separate direct effects of agonists on colonic epithelial cells from indirect effects involving 
enteric nerves or the release of other factors from cells within the lamina propria. To eliminate 
the problems associated with native colonic epithelial sheets, cell lines derived from human 
colonic carcinomas (T84, HT-29, and Caco-2) have been used. These cell lines grow as 
confluent monolayers, retain cellular polarity, form intercellular tight junctions, exhibit ion 
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transport, respond to hormones and neurotransmitters, and undergo morphologic and functional 
transformation in response to changes in their external environment. The T84 cell line is a 
convenient model to study colonic Cl¯ secretion and crypt cell function. 
I have investigated the nongenomic effects of 17 β-estradiol on epithelial Cl¯ secretion 
using the T84 cell line. Condliffe and others (2001) have reported that a physiological 
concentration of 17 β-estradiol rapidly reduced the forskolin stimulation of Cl¯ secretion in the 
distal colon of female rats. Additionally, in the rat distal colonic epithelium, a brief incubation of 
distal colonic epithelial sheets with 10-100 nM concentration of 17 β-estradiol significantly 
reduced the Cl¯ secretory responses to Ca2+ dependent secretagogue carbachol (Condliffe and 
others 2001). I used T84 monolayers to confirm these findings and develop a tissue culture 
model to study the rapid effects of 17 β-estradiol on epithelial Cl¯ secretion.  
Initial experiments were developed to confirm the observations of Singh and others 
(2000) who have used T84 monolayers to study epithelial Cl¯ secretion. Singh and others (2000) 
have reported that 17 β-estradiol caused a rapid and reversible inhibition of forskolin-stimulated 
Cl¯ secretion across T84 monolayers with a Ki of 8 µM. 17 α-estradiol was equipotent with 17 β-
estradiol, arguing against a genomic-mediated mechanism of action. Their data suggested that 
estrogens can interact directly with CFTR to alter anion transport. My initial experiments 
confirmed the observations of Singh and others (2000). I found that 17 β-estradiol inhibited 
forskolin-stimulated Cl¯ within seconds and in a dose-dependent manner. The inhibitory effect of 
17 β-estradiol on Cl¯ secretion was greater when applied to the apical side of the monolayers 
consistent with 17 β-estradiol and other steroids acting as blockers of the CFTR Cl¯ channels, as 
reported earlier (Singh and others 2000).  
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I have used thapsigargin and carbachol to stimulate Cl¯ secretion by raising intracellular 
calcium. Contrary to the observations of Condliffe and others (2001), my studies have revealed 
that 17 β-estradiol potentiates Ca2+ dependent Cl¯ secretion. Supraphysiological concentrations 
of  17 β-estradiol were required to elicit rapid responses in T84 monolayers.  I have found that 17 
β-estradiol has two contrasting effects on epithelial Cl¯ secretion. 17 β-estradiol inhibits cAMP-
stimulated chloride secretion, but potentiates calcium-stimulated chloride secretion. The 
inhibitory effects on cAMP-stimulated chloride secretion are consistent with steroids acting as a 
CFTR channel blocker (Singh and others 2000). With respect to the potentiation of calcium-
stimulated chloride secretion, 17 β-estradiol might enhance the calcium sensitivity of CFTR 
activation. The mechanism of potentiation of calcium-stimulated chloride secretion has been 
delineated in this investigation.  
A better knowledge of the nongenomic actions of estrogens on colonic epithelia will help 
understand epithelial ion transport and open new perspectives in the pharmacological treatment 
of pathological conditions like cystic fibrosis and secretory diarrhea. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
Cell Culture 
 The human colonic cell line T84 was used for this investigation. Cultures were initiated 
from T84 stocks maintained in liquid nitrogen. Unless indicated otherwise, T84 cells were grown 
to confluence in T-75 culture flasks in Dulbeccos modified Eagles medium and Hams F-12 
(1:1) (DME/F12, Sigma, St. Louis, MO) supplemented with 15 mM HEPES, 2 mM glutamine, 
5% new born calf serum (NBCS, Sigma, St. Louis, MO), 100 U/ml penicillin, and 100 µg/ml 
streptomycin. Cultures were maintained at 37ºC in an atmosphere of 5% CO2-95% air. The 
confluent T84 cultures were trypsinized and subcultured (1:3) at weekly intervals. Cells from 
passages 35-47 were used in experiments. Cultures were fed fresh medium every other day and 
day before use. 
 
Electrophysiology 
For electrophysiological studies, 5 X 105 cells were seeded in Millicell-HA or Millicell-
PCF (Millipore, Bedford, MA) culture plate inserts (12 mm diameter; 0.6 cm2 surface area). 
Epithelial monolayer development was monitored daily by measuring transepithelial electrical 
resistance (Rte) with an epithelial volt-ohm meter (EVOM) apparatus (World Precision 
Instruments). Maximal Rte  (1500-3500 Ω.cm2) developed between days 6 and 12 of culture. To 
maintain sterility, EVOM electrodes were soaked in 70% ethanol for a few minutes then rinsed 
in sterile phosphate-buffered saline (PBS) before use.  
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Short-circuit current (ISC) is the current that must be passed across the epithelial 
monolayer to reduce the transepithelial voltage to 0 mV. For ISC measurements (except 
experiments performed to study basolateral membrane K+ channel activity), Millicells were 
mounted in water-jacketed Ussing chambers and bathed in bicarbonate-buffered Ringer solution 
(composition in mM: 125 NaCl, 5 KCl, 1.5 CaCl2, 1.5 MgCl2, 25 NaHCO3, 5 glucose, and 
0.0005% phenol red) with continuous bubbling of 95% O2 -5% CO2. The potential difference 
across the epithelial monolayer was measured with calomel electrodes in 3M KCl and monitored 
with a current-voltage clamp (Physiologic Instruments, San Diego). Monolayer potential was 
clamped to 0 mV with Ag/AgCl2 electrodes connected to the Ussing chambers by agar bridges. 
At 20 or 30 sec intervals, a biphasic pulse of 5 mV was applied and the resulting current 
deflection used to calculate monolayer conductance (G) by Ohms law. Output from the current-
voltage clamp was recorded on a Pentium-based microcomputer equipped with a DATAQ data 
acquisition board (DATAQ Instruments Inc., Akron OH) running Acquire and Analyze software 
(Physiologic Instruments). 
 To stimulate cAMP dependent Cl¯ secretion, 10 µM forskolin was added to the 
basolateral hemichamber. Forskolin causes ISC to rise sharply and plateau at a stable ISC within 15 
minutes. ISC is fully reflective of Cl¯ secretory activity (McRoberts and Barrett 1989). 17 β-
estradiol or other steroids were added from 1000X ethanol stock solutions to both the apical and 
basolateral hemichambers (unless noted otherwise), and the effects of steroids on forskolin-
stimulated ISC was noted. To study the rapid effects of steroids on Ca2+ -dependent Cl¯ secretion, 
17 β-estradiol and other steroids were added from 1000X ethanol stock solutions to both the 
apical and basolateral hemichambers, unless noted otherwise. To stimulate Ca2+ -dependent Cl¯ 
secretion, 100 µM carbachol (100X in Ringer) was added to the basolateral hemichamber or 1 
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µM thapsigargin (1000X in DMSO) was added to the apical hemichamber. These secretagogues 
cause a rise in cytosolic calcium and produce a transient increase in ISC that peaks in 1 and 10 
minutes respectively. Effects of steroids and other compounds on Cl¯ secretion were determined 
by comparing effects on peak ISC values after carbachol or thapsigargin addition. A vehicle 
control (0.1% ethanol) was included in all experiments. 
 Basolateral membrane K+ channel activity in T84 monolayers was determined in nystatin-
permeabilized monolayers by methods similar to those described previously (Ecay and Valentich 
1993). Monolayers were mounted in Ussing chambers, bathed in HEPES-buffered Ringer 
(composition in mM: 125 NaCl, 5 KCl, 1.5 CaCl2, 1.5 MgCl2, 10 HEPES, and 5 glucose) and 
voltage clamped. Standard HEPES-buffered Ringer solution was replaced with HEPES-buffered 
Ringer solutions formulated to produce a 140:5 mM apical to basolateral K+ gradient (apical 
Ringer composition in mM: 140 Kgluconate, 10 NaGluconate, 1 CaGluconate, 1 MgSO4, 10 
HEPES, and 10 glucose; basolateral Ringer composition in mM: 5 Kgluconate, 135 N-methyl-D-
glucamine gluconate, 10 NaGluconate, 1 CaGluconate, 1 MgSO4, 10 HEPES, and 10 glucose). 
Ringer solution was continuously bubbled with 100 % O2. The apical membrane was 
permeabilized with 350 µg/ml nystatin (Sigma, St. Louis, MO), and gassing of the apical 
hemichamber was reduced to minimize frothing. The spontaneous sodium current produced by 
nystatin permeabilization was blocked by addition of 50 µM ouabain (Calbiochem, LaJolla, OR) 
to the basolateral hemichamber. After a 5-minute incubation, 17 β-estradiol was added to both 
the apical and basolateral hemichambers, and after 20 minutes 1 µM thapsigargin was added to 
activate the basolateral K+ channels. The rapid rise in K+ current (IK) was recorded. 
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Measurement of Intracellular Ca2+ Concentration 
 For studies involving measurement of intracellular free Ca2+ concentration, the T84 cells 
were grown to confluency on sterile 150 mm plastic tissue culture dishes. In initial experiments, 
trypsinizing cells immediately prior to assay resulted in fragile cells, a significant fraction of 
which died during fura 2-acetoxymethyl ester (fura-2) loading and fluorescence measurements. 
Cell viability was assayed by trypan-blue exclusion. To enhance cell viability, cultures were 
trypsinized the day before an experiment and maintained overnight as a suspension in Sigmacote 
treated 150 mm plastic tissue culture dishes. Under these conditions the cells attached poorly to 
plastic and could be easily detached and resuspended the following day. Mild trypsinization was 
sometimes required to bring cells back to suspension. Approximately 5 X 106 cells were used in 
each experiment. Cells were washed and resuspended in HEPES saline buffer  (pH 7.45, 
composition in mM: 145 NaCl, 5 KCl, 1 MgSO4, 2 CaCl2, 10 HEPES and 10 Glucose). Cells 
were loaded with 3 µM fura-2 for 30 min at 22º C. Fura-2 used in these experiments was 
obtained from Molecular Probes (Eugene, OR). It has been shown that the organic anion 
transport inhibitor probenecid (2.5 mM) suppresses fura-2 extrusion from various cells (Di 
Virgilio and others 1988; McDonough and Button 1989). To prevent extrusion of fura-2 from 
T84 cells, 2.5 mM probenecid was added to the fura-2 loaded cell suspension and the cells 
further incubated for 10 min. Then these cells were washed twice with HEPES saline buffer and 
resuspended in HEPES saline buffer containing 2.5 mM probenecid. 2.5 ml of the fura-2 loaded 
resuspended cell suspension was loaded in a standard 1 cm2 quartz cuvette, 17 β-estradiol (or 
vehicle control) added, and after 20 minutes the cells were stimulated with 2 µM thapsigargin.  
The cuvette temperature was maintained at 37ûC with constant stirring throughout the 
experiment. Intracellular Ca2+ was measured over a period of 15 minutes. Intracellular Ca2+ was 
 35
determined by measuring fura fluoresecence at 510 nm, using 340/380-nm dual wavelength 
excitation in a SPEX Fluoromax-3 Spectrofluorometer (Jobin Yvon-Spex, Edison, NJ). 
Intracellular calcium [Ca2+]i  was calculated with DataMax for Windows software (Jobin Yvon-
Spex, Edison, NJ) using the equation (Grynkiewicz and others 1985), [Ca2+]i = Kd X bX (R-
Rmin)/ (Rmax-R), where  R is the measured fluorescence ratio. Calibration was performed at the 
end of each experiment by lysing the cells with addition of 25 µM digitonin to determine Rmax 
(the maximum 340/380 nm ratio of  fura-2 fluorescence), and Rmin (the minimum 340/380 
fluorescence ratio) was obtained by addition of  10 mM EGTA (pH 7.4). Kd is the dissociation 
constant of the fura-2/Ca2+ complex (140 nM), and b is the ratio of fluorescence at 380 nm at 
zero and saturating Ca2+ concentration.    
 
Statistical Analysis 
 
The data shown are either original traces or mean values ± standard error of the mean 
(SEM). Data analysis was done using Sigmaplot and SigmaStat software (SASS, Chicago, IL). 
The variance amongst each group was not always equal (equal variance test failed in many 
experiments), hence the ANOVA analysis is not an appropriate statistical test. Statistical 
significance (p < 0.05) was determined by using the Students t-test.  
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CHAPTER 3 
RESULTS 
 
17 β-estradiol and other Steroids Inhibit Forskolin-stimulated Cl¯ Secretion 
 T84 monolayer cultures were mounted in Ussing chambers and voltage clamped at 0 mV. 
Short-circuit current (ISC), which is fully reflective of Cl¯ secretory activity (McRoberts and 
Barrett 1989) was stimulated by addition of 10 µM forskolin to the basolateral hemichamber. 
Prior to stimulation, the cultures exhibited a low and stable basal current (1.5-3 µA/cm2). 
Forskolin stimulation caused ISC to rise sharply and plateau to a stable value that ranged from 30-
40 µA/cm2. 17 β-estradiol and other steroids were added from 1000X ethanol stock solutions to 
both the apical and basolateral hemichambers, and the effect of these steroids on forskolin-
stimulated ISC was noted.  
Following forskolin stimulation, addition of 17 α-estradiol, 17 β-estradiol, testosterone, 
progesterone, or the synthetic estrogen diethylstilbestrol to both hemichambers caused an 
immediate decline in ISC. This inhibition of forskolin-stimulated Cl¯ secretion was rapid (within 
seconds) and dose-dependent (Figures 4, 5 and Table 1). Diethylstilbestrol was the most potent 
inhibitor of Cl¯ secretion tested, followed by progesterone, testosterone, and the naturally 
occurring estrogens 17 α- and 17 β-estradiol (Figure 5, Table 1). 17 α-estradiol, a stereoisomer 
that does not activate nuclear estrogen receptors, had similar potency to 17 β-estradiol (Figure 5, 
Table 1), confirming that the effect was nongenomic. The inhibitory effect of 17 β-estradiol on 
Cl¯ secretion was greater when applied to the apical side of the monolayers (Figure 4D) 
consistent with 17 β-estradiol and other steroids acting as blockers of the CFTR Cl¯ channels, as 
reported previously (Singh and others 2000).  
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 Corticosterone, d-aldosterone, and the antiestrogen tamoxifen failed to inhibit forskolin- 
stimulated Cl¯ secretion in T84 monolayers (Figure 4C, Table 1). 
 
 
 
 
 
Figure 4  Nongenomic Effect of Steroids on Forskolin-stimulated Cl¯ Secretion in T84 
Monolayers. T84 monolayers were mounted in Ussing chambers, voltage clamped and Cl¯ 
secretion stimulated by addition of 10 µM forskolin to the basolateral hemichamber. Forskolin 
caused ISC to rise sharply and plateau to a stable ISC. At this point steroids (50 µM) were added to 
both the apical and basolateral hemichambers, unless indicated otherwise. (A) 17 β-estradiol 
(17β-E2) caused rapid inhibition (within seconds) of forskolin-stimulated Cl¯ secretion (n=3). 
(B) progesterone was a more potent inhibitor of  cAMP-stimulated chloride secretion compared 
to 17β-E2 (n=3). (C) Corticosterone did not inhibit forskolin-stimulated chloride secretion (n=3). 
The antiestrogen tamoxifen and d-aldosterone also failed to inhibit Cl¯ secretion (data shown in 
Table 1). (D) The inhibitory effects of 17β-E2 on Cl¯ secretion are greater when applied to the 
apical side of the monolayer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Figure 4 (continued) 
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Figure 5  Treatment of T84 Monolayers with Steroid causes Dose-dependent Inhibition of 
Forskolin-stimulated Chloride Secretion. T84 monolayers were mounted in Ussing chambers, 
voltage clamped and Cl¯ secretion stimulated by addition of 10 µM forskolin to the basolateral 
hemichamber. Forskolin caused ISC to rise sharply and plateau to a stable ISC. At this point 
steroids (at increasing concentration) were added to both the apical and basolateral 
hemichambers and ISC recorded . ISC/ISC max were plotted against steroid concentration (µm). The 
synthetic estrogen diethylstilbestrol is the most potent inhibitor of chloride secretion tested, 
followed by progesterone, testosterone, and the naturally occurring estrogens 17 β-estradiol 
(17β-E2) and 17 α- estradiol (17α-E2). Values shown are the mean ± SEM, n=3. 17α-E2 does not 
activate a nuclear estrogen receptor confirming that this effect is nongenomic. 
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Table 1  Inhibition of Forskolin-stimulated Chloride Secretion across T84 Monolayers 
 
Steroid Tested (50 µM) 
 
  ISC/ISC max 
diethylstilbestrol  .08 ± .003   (3) 
progesterone  .22 ± .03     (3)  
testosterone  .50 ± .01     (3) 
17β-E2  .59 ± .05     (3) 
17α-E2  .66 ± .03     (3) 
corticosterone     1 ± .03     (3) 
d-aldosterone     1              (2) 
tamoxifen 1.53 ± .26    (3) 
 
 
 
 
17 β-estradiol Potentiates Thapsigargin- and Carbachol-stimulated Cl¯ Secretion 
 T84 monolayers were mounted in Ussing chambers, voltage clamped, and treated with a 
bilateral addition of 17 β-estradiol. Addition of 17 β-estradiol always caused a small (< 2 
µA/cm2) and stable increase in ISC. After 15-20 minutes of treatment with 17 β-estradiol, the 
monolayers were stimulated with either 1 µM thapsigargin or 100 µM carbachol. Stimulation of 
T84 monolayers with thapsigargin or carbachol resulted in Ca2+ -dependent Cl¯ secretion. 17 β-
estradiol potentiated  thapsigargin- and carbachol-stimulated Cl¯ secretion. Figure 6 presents data 
from a typical experiment. 
The potentiation of Ca2+ stimulated Cl¯ secretion was dose-dependent, rapid, and steroid 
specific (Figures 7, 8, 9). 17 β-estradiol potentiated thapsigargin-stimulated chloride secretion at 
a concentration as low as 5 µM. Amongst all the other steroids tested (diethylstilbestrol, 
progesterone and testosterone), and the nonsteroidal selective estrogen receptor modulator 
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tamoxifen, no significant potentiation of thapsigargin stimulated Cl¯ secretion was observed at 
the concentration of 5 µM (Figure 8). 
17 β-estradiol potentiated carbachol-stimulated chloride secretion at a concentration of 50 
µM. Potentiation of carbachol-stimulated chloride secretion could be observed at 17 β-estradiol 
concentration as low as 10 µM, but this potentiation was not consistently reproducible. At 50 µM 
concentration, the steroids corticosterone, d-aldosterone and nonsteroid tamoxifen did not 
potentiate carbachol-stimulated Cl¯ secretion. Figure 9B shows the lack of an effect of 
corticosterone on carbachol-stimulated ISC. 
  For potentiation of thapsigargin-stimulated ISC, 17 α-estradiol and 17 β-estradiol were 
equipotent (Figure 8B), confirming that this effect is nongenomic. Apical 17 β-estradiol caused a 
significantly greater potentiation of  carbachol-stimulated Cl¯ secretion, than basolateral 17 β-
estradiol (Figure 9A).
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Figure 6  17 β-estradiol Potentiates Thapsigargin-and Carbachol-stimulated Cl¯ Secretion. This 
figure shows individual short-circuit current recording from a typical experiment. In these 
examples, 17 β-estradiol (17β-E2) potentiated thapsigargin-stimulated Cl¯ secretion (ISC) by 3.5 
fold compared to the 0.1% ethanol controls (115.0 ± 6.7 vs. 31.8 ± 4.1 µA/cm2, respectively 
(mean ± SEM, n=3)). Carbachol-stimulated ISC was potentiated 2.5 fold by 17β-E2 (140.7 ± 1.0 
vs. 56.0 ± 1.5 µA/cm2 (mean ± SEM, n=3)).  
B
T im e  ( m in )
0 1 0 2 0 3 0
I S
C
(µ
A/
cm
2 )
0
4 0
8 0
1 2 0
1 6 0
5 0  µ M
1 7 β − E 2
1 0 0  µ M
C a r b a c h o l
0 . 1 %  e t h a n o l
5 0  µ M  1 7 β - E 2
A
T im e  ( m in )
0 1 0 2 0 3 0 4 0
I S
C
(µ
A/
cm
2 )
0
4 0
8 0
1 2 0
1 6 0
5 0  µ M  1 7 β − E 2
0 . 1 %  e t h a n o l
5 0  µ M
1 7 β - E 2
1  µ M
T h a p s i g a r g i n
 43
Time (min)
0 5 10 15 20 25 30
I S
C
( µ
A/
cm
2 )
0
1
2
3
4
5
6
7
8
1 µM
Thapsigargin
5 µM
17β−Ε2
5 µM 17β−Ε2
0.1% ethanol
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7  Estrogen Potentiation of Ca2+ -stimulated ISC is Dose-dependent, and Very Rapid. 
A. T84 monolayers were mounted in Ussing chambers and voltage clamped. Increasing 
concentrations of 17 β-estradiol (17β-E2) were added to each hemichamber 20 min prior to 
stimulation of Cl¯ secretion by addition of 1 µM thapsigargin to the apical hemichamber. 
Significant potentiation was observed at and above 5 µM 17β-E2. Values are the mean ± SEM 
for 3 to 12 monolayers at each point. Thapsigargin-stimulated ∆ISC for vehicle control (0.1% 
ethanol) was 20.42 ± 1.90 µA/cm2 (n=12).  
B. T84 monolayers were mounted in Ussing chambers and voltage clamped. Cl¯ secretion was 
stimulated with 1 µM thapsigargin. After the peak ISC response, 5 µM 17β-E2 or 0.1% ethanol 
(vehicle control) was added to both hemichambers. 17β-E2 caused a rapid and significant 
increase in ISC. Shown is a representative experiment. 
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Figure 8  Estrogen Potentiation of Ca2+ -stimulated ISC is Dose-dependent, Rapid, and Steroid 
Specific. T84 monolayers were mounted in Ussing chambers, voltage clamped, and treated with 
the indicated steroids (50 µM in A, and 5 µM in B) by addition to both hemichambers. After 20 
min, 1µM thapsigargin was added to stimulate Cl¯ secretion. Thapsigargin-stimulated ISC is 
expressed as a percent of 0.1% ethanol controls (mean ± SEM, number of monolayers in 
parentheses). 17 α-estradiol (17α-E2) and 17 β-estradiol (17β-E2) were equipotent and other 
steroids tested had no significant affect at 5 µM steroid concentration. 
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Figure 9  17 β-estradiol (17β-E2) Potentiates Thapsigargin-and Carbachol-stimulated Cl¯ 
Secretion. A. T84 monolayers were mounted in Ussing chambers and voltage clamped. 17β-E2 
(50 µM ) was added to the apical or basolateral hemichamber 20 min prior to stimulation of Cl¯ 
secretion with 100 µM carbachol. Apical 17β-E2 caused a significantly greater potentiation of 
ISC compared to basolateral 17 β-E2. Values shown are the mean ± SEM. The number of 
monolayers in each group is indicated in parentheses. 
B. T84 monolayers were mounted in Ussing chambers, voltage clamped, and treated with 50µM 
17β-E2 or corticosterone by addition to both hemichambers. After 20 min, 100 µM carbachol 
was added to stimulate Cl¯ secretion. Corticosterone did not cause any potentiation. Values 
shown are the mean ± SEM. The number of monolayers in each group is indicated in 
parentheses.
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17 β-estradiol Potentiation of Thapsigargin-and Carbachol Stimulated Chloride Secretion in T84 
Monolayers Grown in Steroid Free Culture Media  
 
The culture media used to grow T84 monolayers contains 5% newborn calf serum 
(NBCS) that has small amounts of estrogens and other steroids. Phenol red in the culture media 
also has weak estrogenic activity (Berthois and others 1986). To exclude the effects of steroids in 
the culture media, several experiments were conducted with T84 monolayers grown in phenol 
red-free DME/F12 supplemented with 15 mM HEPES, antibiotics, and charcoal-stripped 
(steroid-free) NBCS. Steroids were removed from NBCS (charcoal-stripped) by adding 2% 
weight/volume charcoal and heating to 55ºC for 1 hour. The charcoal was removed by 
centrifugation, and the serum was sterilized by gentle filtration through a 0.22 µ Millipore filter. 
Phenol red-free bicarbonate-buffered Ringer solution was used in these experiments.  
17 β-estradiol potentiation was not enhanced in monolayers grown in steroid-free 
environment. 17 β-estradiol at concentrations lower than 5 µM did not cause significant 
potentiation of thapsigargin- or carbachol-stimulated Cl¯ secretion in monolayers that were 
serum starved and/or grown in steroid-free culture media (Figure 10, 11). As cultures grown 
under serum-free conditions did not alter the response of T84 monolayers to 17 β-estradiol, 
subsequent experiments used monolayers and cells cultured in standard culture medium and 
unstripped serum.
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Figure 10  17 β-estradiol (17β-E2) Potentiation of Thapsigargin-and Carbachol-stimulated 
Chloride Secretion is not Significant at Lower (1µM) 17β-E2 Concentrations in T84 Monolayers 
Grown in Steroid-free Media. T84 monolayers were grown in phenol red-free culture media and 
treated with charcoal-stripped (steroid-free) 5% NBCS for 3 days prior to experimentation. T84 
monolayers were mounted in Ussing chambers, voltage clamped, and treated with a bilateral 
addition of 1 µM 17β-E2, 20 min prior to stimulation with either 100 µM carbachol (A) or 1 µM 
thapsigargin (B). No significant potentiation was observed. Values shown are mean ± SEM (n in 
parentheses). 
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Figure 11  17 β-estradiol (17β-E2) Potentiation of Thapsigargin-and Carbachol-Stimulated 
Chloride Secretion is not Significant at Lower 17β-E2 Concentrations  in Serum-starved T84 
Monolayers Grown in Steroid-free Media. T84 monolayers were grown in phenol red-free 
culture media and treated with charcoal-stripped (steroid-free) 5% NBCS for 3 days and 
charcoal-stripped (steroid-free) 0.5% NBCS for 24 hours prior to experimentation. T84 
monolayers were mounted in Ussing chambers, voltage clamped, and treated with a bilateral 
addition of  17β-E2, 20 min prior to stimulation with either 100 µM carbachol (A) or 1 µM 
thapsigargin (B). No significant potentiation was observed. Values shown are mean ± SEM (n in 
parentheses). 
 
B 
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Tamoxifen, does not Block 17 β-estradiol Potentiation of Ca2+ -stimulated Cl¯ Secretion 
 To study whether tamoxifen (a nonsteroidal triphenylethylene), a competitive inhibitor of 
estrogen binding to nuclear estrogen receptors, blocked the 17 β-estradiol potentiation of Cl¯ 
secretion, T84 monolayers were mounted in Ussing chambers, voltage clamped, and 
preincubated with 50 µM tamoxifen for 30 min prior to addition of 5 µM 17 β-estradiol. Twenty 
minutes after addition of 17 β-estradiol, Cl¯ secretion was stimulated with 1 µM thapsigargin. 
Tamoxifen by itself did not have any effect on thapsigargin-stimulation. Tamoxifen did not block 
17 β-estradiol potentiation of thapsigargin-stimulated Cl¯ secretion (Figure 12), instead it 
potentiated the 17 β-estradiol response (p< 0.05). The observation that tamoxifen did not block 
17 β-estradiol potentiation of thapsigargin-stimulated Cl¯ secretion suggests that the classical 
nuclear estrogen receptors are not involved. 
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Figure 12  Tamoxifen does not Block 17 β-estradiol (17β-E2) Potentiation of Ca2+ -stimulated 
Cl¯ Secretion. T84 monolayers were mounted in Ussing chambers, voltage clamped and 
preincubated with 50 µM tamoxifen (a nonsteroidal triphenylethylene antiestrogen) for 30 min 
before addition of 5 µM 17β-E2. After 20 min, Cl¯ secretion was stimulated with 1 µM 
thapsigargin. Values shown are the mean ± SEM for the peak thapsigargin response (n in 
parentheses). Tamoxifen did not block 17β-E2 potentiation suggesting that the classical nuclear 
estrogen receptors are not involved in this action of 17β-E2. 
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17 β-estradiol Potentiation of Ca2+-stimulated Cl¯ secretion Coincides with an Increase in 
Monolayer Electrical Conductance 
T84 monolayers were mounted in Ussing chambers, voltage clamped, and treated with  
17 β-estradiol for 20 minutes prior to stimulation of Cl¯ secretion with 1 µM thapsigargin or 100 
µM carbachol. At 20 or 30 sec intervals, a biphasic pulse of 5 mV was applied and the resulting 
current deflection used to calculate monolayer conductance (G) by Ohms law. 17 β-estradiol 
treatment by itself did not cause any change in monolayer electrical conductance. Thapsigargin 
or carbachol stimulation caused a significant increase in monolayer conductance in 17 β-estradiol 
treated monolayers compared to 0.1% ethanol controls. A significantly increased conductance in 
17 β-estradiol treated monolayers suggests that 17 β-estradiol causes the opening of additional 
ion channels following thapsigargin or carbachol stimulation. Figure 13 shows original tracings 
from a typical experiment.
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Figure 13  17 β-estradiol (17β-E2) Potentiation of Ca2+-stimulated Cl¯ Secretion Coincides with 
an Increase in Monolayer Electrical Conductance. T84 monolayers were mounted in Ussing 
chambers, voltage clamped, and treated with 5 µM 17β-E2 for 20 min prior to stimulation of Cl¯ 
secretion with 1 µM thapsigargin. Shown are individual recordings of ISC and monolayer 
conductance (G) from 2 monolayers in a typical experiment. The significantly increased 
conductance in 17β-E2-treated monolayers suggests that 17β-E2 causes the opening of additional 
ion channels following thapsigargin stimulation. 
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The Chloride Channel Blockers NPPB and DIDS do not Reduce 17 β-estradiol Potentiation of 
Thapsigargin-or Carbachol-stimulated Cl¯ Secretion 
To test whether 17 β-estradiol caused activation of additional apical Cl¯ channels, T84 
monolayers were treated with the Cl¯ channel blockers DIDS or NPPB before addition of 17 β-
estradiol. DIDS, a disulfonic stilbene, does not affect CFTR when added to the extracellular side 
of the membrane, and NPPB, an arylaminobenzoate, is a partial CFTR blocker (Gray and others 
1993; Schultz and others 1999). T84 monolayers were mounted in Ussing chambers, voltage 
clamped, and treated with either 50 µM NPPB or 100 µM DIDS (by addition to the apical 
hemichamber) for 30 minutes to block activity of Ca2+ -activated Cl¯ channels. Next, monolayers 
were treated with 17 β-estradiol for 20 minutes prior to stimulation of Cl¯ secretion with 1 µM 
thapsigargin or 100 µM carbachol. The results showed that 17 β-estradiol potentiation of 
carbachol-stimulated Cl¯ secretion was partially reduced in monolayers treated with NPPB, 
consistent with partial block of CFTR by NPPB (Gray and others 1993). However, in 
monolayers treated with DIDS 17 β-estradiol potentiation was unaffected (Figure 14). There was 
no significant change in 17 β-estradiol (5 µM steroid concentration) potentiation of thapsigargin-
stimulated Cl¯ secretion in either NPPB or DIDS treated monolayers (Figure 15). These results 
suggest that 17 β-estradiol potentiation of thapsigargin or carbachol -dependent Cl¯ secretion 
does not involve activation of Cl¯ channels other than CFTR in T84 cells.
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Figure 14  The Effect of Chloride Channel Blockers NPPB and DIDS on 17 β-estradiol (17β-E2) 
Potentiation of Carbachol -stimulated Cl¯ Secretion. T84 monolayers were mounted in Ussing 
chambers, voltage clamped, and treated with either 50 µM NPPB (A) or 100 µM DIDS (B) for 
30 min to block activity of Ca2+ -activated Cl¯ channels. Next, monolayers were treated with 50 
µM 17β-E2 for 20 min prior to stimulation of Cl¯ secretion with 100 µM carbachol. Values 
shown are the mean ± SEM (n in parentheses) for the peak ISC response. These results show that 
17β-E2 potentiation of carbachol-stimulated Cl¯ secretion is decreased in monolayers treated 
with NPPB, but not in monolayers treated with DIDS.
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Figure 15  The Chloride Channel Blockers NPPB and DIDS do not Reduce 17 β-estradiol 
Potentiation of Thapsigargin-stimulated Cl¯ Secretion. T84 monolayers were mounted in Ussing 
chambers, voltage clamped, and treated with either 50 µM NPPB (A) or 100 µM DIDS (B) for 
30 min to block activity of Ca2+ -activated Cl¯ channels. Next, monolayers were treated with 5 
µM 17β-E2 for 20 min prior to stimulation of Cl¯ secretion with 1 µM thapsigargin. Values 
shown are the mean ± SEM (n in parentheses) for the peak ISC response. These results suggest 
that 17β-E2 potentiation of thapsigargin -dependent Cl¯ secretion does not involve activation of 
Cl¯ channels other than CFTR in T84 cells. 
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17 β-estradiol Potentiation of Thapsigargin-or Carbachol-stimulated Cl¯ Secretion Requires 
Active CFTR Cl¯ Channels 
H89, an inhibitor of cAMP-dependent protein kinase A (PKA), was used to study the 
activity of the apical CFTR Cl¯ channels in T84 monolayers. T84 monolayers were pretreated for 
30 minutes with 30 µM H89, voltage clamped, then treated with 50 µM 17 β-estradiol (20 
minutes), prior to stimulation of Cl¯ secretion with 100 µM carbachol. H89 treatment caused a 
small (statistically insignificant) decrease in carbachol-stimulated ISC and 17 β-estradiol 
potentiation of carbachol-stimulated ISC (Figure 16). Treatment of monolayers with 30 µM H89 
for 30 minutes partially blocked cAMP dependent Cl¯ secretion (forskolin-stimulated ISC 
decreased from 23.4 ± .26 µA/cm2 to 13.92 ± 1.19 µA/cm2 (mean ± SEM, n=4)), indicating that a 
much longer period of incubation with H89 is required for complete inhibition of PKA.  
In subsequent experiments, monolayers were preincubated for 4 hours with 30 µM H89 
to study the effect of H89 on 17 β-estradiol potentiation. T84 monolayers were preincubated for 
4 hours with 30 µM H89, mounted in Ussing chambers, voltage clamped and treated with 17 β-
estradiol for 20 minutes prior to stimulation with 1 µM thapsigargin. H89 treatment blocked 
thapsigargin-stimulated ISC in T84 monolayers grown in Millicell-PCF culture plate inserts, 
consistent with CFTR being the only apical Cl¯ channel in T84 cells (Figure 17A). H89 treatment 
did not block thapsigargin-stimulated ISC in monolayers grown in Millicell-HA inserts (Figure 
17B). This was probably due to the difference in the culture plate inserts used. H89 treatment 
completely blocked 17 β-estradiol potentiation of thapsigargin-stimulated ISC in all monolayers 
(Figure 17). These observations suggest that the 17 β-estradiol potentiation of Ca2+-     
stimulated Cl¯ secretion requires active CFTR Cl¯ channels.
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Figure 16  17 β-estradiol Potentiation of Carbachol-stimulated Cl¯ Secretion Requires Active 
CFTR Cl¯ Channels. T84 monolayers were preincubated for 30 min with 30 µM H89, an 
inhibitor of cAMP-dependent protein kinase A (PKA). After H89 treatment, monolayers were 
mounted in Ussing chambers, voltage clamped and 30 µM H89 added to each hemichamber. 
Monolayers were treated with 50 µM 17 β-estradiol (17β-E2) for 20 min prior to stimulation of 
Cl¯ secretion with 100 µM carbachol. Values shown are the peak carbachol response for each 
group (mean ± SEM, n in parentheses). H89 treatment decreases carbachol-stimulated ISC and 
17β-E2 potentiation, consistent with CFTR being the only apical Cl¯ channel in the T84 cell. 
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Figure  17  17 β-estradiol Potentiation of Thapsigargin-stimulated Cl¯ Secretion Requires Active 
CFTR Cl¯ Channels. T84 monolayers were preincubated for 4 hours with 30 µM H89, an 
inhibitor of cAMP-dependent protein kinase A (PKA). After H89 treatment, monolayers were 
mounted in Ussing chambers, voltage clamped and 30 µM H89 added to each hemichamber. 
Monolayers were treated with 17β-E2 (5 µM in panel A and 50 µM in panel B) for 20 min prior 
to stimulation of Cl¯ secretion with 1 µM thapsigargin. H89 treatment blocked thapsigargin-
stimulated ISC (in panel A) and 17β-E2 potentiation (both in panel A and panel B), consistent 
with CFTR being the only apical Cl¯ channel in the T84 cell. Values shown are the peak 
response for each group (mean ± SEM, n in parentheses).  
B 
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17 β-estradiol Does not Increase the Activity of Ca2+-activated K+ Channels in the Basolateral 
Membrane of T84 Monolayers 
 
 A significantly increased conductance in 17 β-estradiol treated monolayers suggested that 
17 β-estradiol caused the opening of additional ion channels following thapsigargin (or 
carbachol) stimulation (Figure 13). Also, the 17 β-estradiol potentiation of thapsigargin- or 
carbachol -dependent Cl¯ secretion did not involve activation of apical Cl¯ channels other than 
CFTR in T84 cells (Figures 14,15). Experiments were conducted to determine whether 17 β-
estradiol increased the activity of Ca2+-activated K+ channels in the basolateral membrane of T84 
monolayers. 
 T84 monolayers were mounted in Ussing chambers and voltage clamped. The ringer 
solution bathing the monolayers was changed to impose a 140:5 mM apical to basolateral K+ 
gradient. The apical membrane was permeabilized with nystatin (350 µg/ml), and the basolateral 
spontaneous sodium current was blocked by addition of ouabain (50 µM). At this point, 
monolayers were incubated for 20 minutes with 5 µM 17 β-estradiol, and stimulated with 1 µM 
thapsigargin to activate basolateral K+ channels. 17 β-estradiol did not change the thapsigargin-
stimulated IK, suggesting that activation of basolateral membrane K+ channels is not the target 
for 17 β-estradiol action (Figure 18). Similar results have been obtained with T84 monolayers 
treated with 50 µM 17 β-estradiol and stimulated with 100 µM carbachol (Conner and Ecay, 
unpublished observations).   
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Figure 18  17 β-estradiol does not Increase the Activity of Ca2+-activated K+ Channels in the 
Basolateral Membrane of T84 Monolayers. T84 monolayers were mounted in Ussing chambers 
and voltage clamped. To measure basolateral membrane K+ channel activity the Ringer solution 
bathing monolayers was changed (at 0 min at A) to impose a 140:5 mM apical to basolateral K+ 
gradient. Next, the apical membrane was permeabilized to monovalent ions with nystatin (350 
µg/ml) and ouabain (50 µM) was added to inhibit the spontaneous sodium current. 17 β-estradiol 
(17β-E2) was added as indicated and after 20 min 1 µM thapsigargin was added to activate 
basolateral K+ channels. Under these conditions, thapsigargin causes a rapid rise in potassium 
current (IK) that also decays rapidly. In the absence of a K+ gradient, there is no change in IK 
after thapsigargin addition (not shown). Panel A presents individual current recordings from a 
typical experiment. Panel B shows the mean ± SEM (n in parentheses) for the peak IK responses. 
These results suggest that activation of basolateral membrane K+ channels is not the target for 
17β-E2 action. 
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17 β-estradiol Potentiation of Ca2+-stimulated Cl¯ Secretion is not Mediated through the PKC or 
MEK Pathways 
T84 monolayers were mounted in Ussing chambers, voltage clamped, and preincubated 
with either bisindolylmaleimide (BIM), a protein kinase C (PKC) inhibitor, or PD 98059, a MAP 
kinase kinase (MEK) inhibitor. At this point the monolayers were treated with 17 β-estradiol for 
20 minutes prior to stimulation of Cl¯ secretion with thapsigargin. BIM did not effect 
thapsigargin-stimulated ISC or its potentiation by 17 β-estradiol. PD 98059 caused a small and 
significant (p< 0.05) potentiation of thapsigargin-stimulated ISC but had no effect on 17 β-
estradiol potentiation. These observations suggest that the activation of PKC or MEK pathways 
are not involved in the 17 β-estradiol effect (Figure 19). 
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Figure 19  17 β-estradiol Potentiation of Thapsigargin-stimulated Cl¯ Secretion is not Mediated 
through the PKC or MEK Pathways. T84 monolayers were mounted in Ussing chambers, voltage 
clamped and preincubated for 30 min with either 1 µM bisindolylmaleimide (BIM), a PKC 
inhibitor (A) or 20 µM PD 98059, a MAP kinase kinase (MEK) inhibitor (B). Next, monolayers 
were treated with 5 µM 17 β-estradiol (17β-E2) for 20 min prior to stimulation of Cl¯  secretion 
with 1 µM thapsigargin. Values shown are the mean ± SEM (n in parentheses) for the peak 
thapsigargin responses. Neither BIM nor PD 98059 reduced thapsigargin-stimulated ISC or its 
potentiation by 17β-E2 suggesting that activation of these pathways is not involved in the 17β-
E2 effect.   
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17 β-estradiol Potentiation of Thapsigargin-stimulated Cl¯ Secretion is Dependent on the 
Presence of Extracellular Ca2+ 
 T84 monolayers were mounted in Ussing chambers, voltage clamped, and the Ringer 
solution bathing the monolayers was changed to Ringer solution containing low Ca2+ or zero 
Ca2+ Ringer. Next, monolayers were briefly treated with 17 β-estradiol before stimulating Cl¯ 
secretion with either thapsigargin or carbachol. 17 β-estradiol potentiation of carbachol-
stimulated ISC did not change. However, 17 β-estradiol potentiation of thapsigargin-stimulated 
Cl¯ secretion was blunted in T84 monolayers bathed in low Ca2+ or zero Ca2+ Ringer (Figure 20). 
 
 
 
 
 
 
 
 
 
 
 
Figure 20  17 β-estradiol Potentiation of Thapsigargin-stimulated Cl¯ Secretion is Dependent on 
the Presence of Extracellular Ca2+. T84 monolayers were mounted in Ussing chambers, voltage 
clamped and the Ringer solution bathing the monolayers was changed to Ringer solution 
containing 100 µM CaCl2 (low Ca2+) in A, B, and C, and 0 µM (zero Ca2+) in D. Next, 
monolayers were treated (for 20 min) with 50 µM 17 β-estradiol (17β-E2) in A and B, and 5 µM 
17β-E2 in C and D, prior to stimulation of Cl¯ secretion with 100 µM carbachol (A) or 1 µM 
thapsigargin (B,C,D). No change in carbachol or thapsigargin-stimulated ISC was observed in the 
presence of low Ca2+ or zero Ca2+ Ringer. 17β-E2 potentiation of carbachol-stimulated ISC did 
not change in monolayers bathed in low Ca2+ Ringer, however 17β-E2 potentiation of 
thapsigargin-stimulated ISC is blocked in monolayers bathed in low Ca2+ or zero Ca2+ Ringer. 
Values shown are the peak response for each group (mean ± SEM, n in parentheses). 
 
          Figure 20 (continued) 
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Figure 20 (continued) 
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17 β-estradiol Decreases Intracellular Ca2+ in Thapsigargin-stimulated T84 Cells 
To study the effect of 17 β-estradiol on intracellular Ca2+ in cells stimulated with 
thapsigargin, T84 cells suspended in HEPES saline buffer were loaded with fura-2 and treated 
with 17 β-estradiol for 20 minutes. Next, the T84 cells were stimulated with 2 µM thapsigargin. 
Intracellular Ca2+ ([Ca2+]i) was determined by measuring fura fluorescence at 510 nm, using 
340/380-nm dual wavelength excitation. A significant decrease in [Ca2+]i in cells pretreated with 
17 β-estradiol was observed (Figure 21). The thapsigargin-stimulated [Ca2+]i in 17 β-estradiol-
treated cells returned closer to basal level at the end of the experiment compared to untreated 
cells (Figure 21D).  
T84 cells suspended in Ca2+ free HEPES saline buffer, briefly treated with 17 β-estradiol 
also showed decrease in [Ca2+]i upon thapsigargin stimulation (Figure 22). 
  
 
 
 
 
 
 
 
Figure 21  17 β-estradiol Decreases Intracellular Ca2+ in Thapsigargin-stimulated T84 Cells. T84 
cells suspended in HEPES saline buffer were loaded with fura-2 and briefly treated (20 min) 
with 17 β-estradiol. Next, the T84 cells were stimulated with 2 µM thapsigargin. Intracellular 
Ca2+ ([Ca2+]i) was determined by measuring fura fluorescence at 510 nm, using 340/380-nm dual 
wavelength excitation. Panels A and C show significant decrease in [Ca2+]i in the presence of 
100 µM and 10 µM 17 β-estradiol respectively. Panel B shows tracing from a representative 
experiment. Panel D shows the ∆[Ca2+]i   compared to basal concentration at the end of 
experiment in cells pretreated with 10 µM 17 β-estradiol. The thapsigargin-stimulated [Ca2+]i in 
17 β-estradiol-treated cells returned closer to basal level at the end of the experiment compared 
to untreated cells.  
 
 
          Figure 21 (continued) 
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Figure 21 (continued) 
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Figure 22  17 β-estradiol Decreases Intracellular Ca2+ in Thapsigargin-stimulated T84 Cells. T84 
cells were loaded with fura-2, suspended in Ca2+ free HEPES saline buffer and briefly treated (20 
min) with 17 β-estradiol. Next, the T84 cells were stimulated with 2 µM thapsigargin. 
Intracellular Ca2+ ([Ca2+]i) was determined by measuring fura fluorescence at 510 nm, using 
340/380-nm dual wavelength excitation. Panels A and B (original tracings) show decrease in 
[Ca2+]i in the presence of 10 µM and 100 µM 17 β-estradiol respectively.
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CHAPTER 4 
DISCUSSION 
 
This study has demonstrated that steroids have two contrasting effects on epithelial 
chloride secretion. First, steroids inhibit cAMP-stimulated chloride secretion. Second, steroids 
potentiate Ca2+-stimulated chloride secretion in T84 monolayers. Both these effects occur within 
minutes (or faster) suggesting that they are nongenomic. 17 α-estradiol, a stereoisomer that does 
not activate any nuclear estrogen receptors, shows potency similar to 17 β-estradiol for inhibition 
and potentiation, confirming that these effects are nongenomic. Tamoxifen and the steroids 
corticosterone and d-aldosterone fail to inhibit cAMP-stimulated Cl¯ secretion or potentiate Ca2+-
stimulated Cl¯ secretion in T84 monolayers even at 50 µM concentrations, confirming that these 
nongenomic effects are not due to steroid induced changes in membrane fluidity. The inhibitory 
effects of sex steroids on Cl¯ secretion is greater when applied to the apical side of the 
monolayers, consistent with steroids acting as blockers of the CFTR Cl¯ channels (Singh and 
others 2000). 17 α- and 17 β-estradiol caused minimum inhibition of forskolin-stimulated Cl¯ 
secretion, but maximum potentiation of Ca2+-stimulated Cl¯ secretion. Diethylstilbestrol caused 
maximum inhibition of forskolin-stimulated Cl¯ secretion, followed by progesterone and 
testosterone. At 5 µM steroid concentrations, diethylstilbestrol, progesterone, or testosterone do 
not have any significant effect on thapsigargin-stimulated Cl¯ secretion.  
My data suggest that the potentiation of Ca2+-stimulated chloride secretion in T84 
monolayers is an estrogen-specific effect. Amongst all the steroids tested, 17 α- and 17 β-
estradiol were the only steroids that consistently produced significant potentiation at a 
concentration as low as 5 µM.  The steroids progesterone and testosterone produced potentiation 
 71
of thapsigargin-stimulated Cl¯ secretion, but only at 50 µM steroid concentrations. At 5 µM 
steroid concentration, the inhibitory action of 17 β-estradiol on cAMP-stimulated chloride 
secretion is minimal compared to its potentiating effect on Ca2+-stimulated chloride secretion. 
Both the inhibitory and potentiating actions of  17 β-estradiol occur simultaneously. 17 β-
estradiol causes a minimal inhibition of cAMP-stimulated chloride secretion by partially 
blocking CFTR Cl¯ channels, but in the presence of increasing intracellular Ca2+ potentiates 
chloride secretion by stimulating the opening of additional conductive pathways. 17 β-estradiol 
may potentiate Ca2+-stimulated chloride secretion by opening store-operated calcium channels, 
increasing the sensitivity of CFTR activation to the rise in intracellular Ca2+ and triggering some 
additional signal transduction pathways.     
 Condliffe and others (2001) have reported that a physiological concentration of 17 β-
estradiol rapidly reduced the forskolin stimulation of Cl¯ secretion in the distal colon of female 
rats. Additionally, in the rat distal colonic epithelium, a brief incubation of distal colonic 
epithelial sheets with 10-100 nM concentration of 17 β-estradiol significantly reduced the Cl¯ 
secretory responses to Ca2+ dependent secretagogue carbachol (Condliffe and others 2001). This 
study has demonstrated that supraphysiological concentration of 17 β-estradiol inhibits cAMP-
stimulated chloride secretion but enhances Ca2+-stimulated chloride secretion in T84 
monolayers. This difference is due to the model of Cl¯ secretion used by Condliffe and others 
(2001). I have used the T84 colonic adenocarcinoma cell line (derived from a 72 year old man) 
to study colonic epithelial Cl¯ secretion whereas Condliffe and others (2001) have used freshly 
dissected distal colonic epithelial sheets obtained from female Sprague-Dawley rats. Apart from 
direct effects of agonists on colonic epithelial cells, epithelial sheets are likely targets of indirect 
effects of enteric nerves or release of other factors from cells within lamina propria. 
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My observations with forskolin-stimulation are similar to those reported by Singh and 
others (2000), but there are subtle differences. Singh and others (2000) have observed that the 
synthetic estrogens (diethylstilbestrol and hexestrol) and the naturally occurring estrogens (17 α- 
and 17 β-estradiol) were the most potent inhibitors of forskolin-stimulated Cl¯ secretion followed 
by progesterone and testosterone. Tamoxifen also caused rapid, reversible, dose-dependent 
inhibition of forskolin-stimulated ISC at a similar concentration as testosterone (Ki= 50 µM). 
Contrary to these findings, my study has shown that diethylstilbestrol is the most potent inhibitor 
of Cl¯ secretion, followed by progesterone, testosterone, and 17 α- and 17 β-estradiol. Tamoxifen 
does not inhibit forskolin-stimulated Cl¯ secretion in T84 monolayers.  
There are several factors that may account for the differences in this study compared to 
that reported by Singh and others (2000). These differences are due to the differences in cell 
passage, culture media, and the culture plate inserts used. Singh and others (2000) have used 
culture media containing 10 % fetal bovine serum, they passaged their cells twice weekly, and 
their T84 cells were seeded in Costar Snapwell cell culture inserts (1.13 cm2). I have used T84 
culture media containing 5 % new born calf serum, passaged cells once a week, and the cells 
were seeded in Millicell-HA culture plate inserts (0.6 cm2). In this study, cAMP-stimulated Cl¯ 
secretion was induced by adding 10 µM forskolin to the basolateral side of the monolayer. Singh 
and others (2000) stimulated Cl¯ secretion by adding 10 µM forskolin to both sides of the 
monolayer. 
Carbachol acts by binding to a basolateral G protein-linked muscarinic receptor and 
causes subsequent hydrolysis of inositol phospholipids. Thapsigargin increases intracellular 
calcium by inhibiting Ca2+-ATPase activity of the endoplasmic reticulum, independent of cell 
surface receptors and hydrolysis of inositol phospholipids. The carbachol- stimulated short-
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circuit current (ISC) is more pronounced but considerably more transient compared to 
thapsigargin-stimulated ISC because of negative regulation by mediators like epidermal growth 
factor, protein kinase C and inositol tetrakisphosphate (Barrett 1993; Barrett 1997). This explains 
why 17 β-estradiol potentiation of carbachol-stimulated Cl¯ secretion is only evident at higher 
concentrations (50 µM or higher) of 17 β-estradiol.   
In most target organs, ERα is the predominant receptor (Lubahn and others 1993). 
However, the predominant estrogen receptor in the human colon and T84 cell line is ERβ 
(Campbell-Thompson and others 2001). A recent immunohistochemical study has confirmed that 
ERβ is highly expressed in superficial and crypt epithelium of normal colon in both males and 
females (Konstantinopoulos and others 2003). Tamoxifen binds to estrogen receptors and 
modulates their transcription function (Clarke and others 2001). Tamoxifen is referred to as a 
selective estrogen receptor modulator because it is known to act as agonist in some tissues but as 
antagonists in others (Grese and Dodge 1998; McDonnell 1999). Tamoxifen can show some 
agonistic activity with ERα but it is a pure antagonist for ERβ (McInerney and others 1998). 
Preincubation of T84 monolayers with tamoxifen does not cause reduction of 17 β-estradiol 
potentiation of Ca2+-stimulated Cl¯ secretion indicating that the classical nuclear estrogen  
receptors are not involved. Future experiments should use pure estrogen receptor antagonists like 
ICI 164384 (Clarke and others 2001; Hall and others 2001) to confirm these findings. 
The 17 β-estradiol potentiation of Ca2+-stimulated Cl¯ secretion caused a significant 
increase in monolayer electrical conductance suggesting that 17 β-estradiol opened additional ion 
channels following stimulation by carbachol or thapsigargin. DIDS, a disulfonic stilbene, is used 
to distinguish CFTR from other types of epithelial Cl¯ channels. DIDS does not affect CFTR 
when added to the extracellular side of the membrane, but potently inhibits other types of Cl¯ 
 74
channels (Schultz and others 1999). The Cl¯ channel inhibitor NPPB, an arylaminobenzoate, has 
been known to partially block single CFTR Cl¯ channels in excised membrane patches (Zhang 
and others 2000), but it is not a specific inhibitor of the CFTR Cl¯ channel (Schultz and others 
1999). The 17 β-estradiol potentiation of carbachol-stimulated Cl¯ secretion was significantly 
decreased in monolayers treated with NPPB, suggesting blocking of CFTR Cl¯ channels by 
NPPB, but no change in 17 β-estradiol potentiation was observed in monolayers treated with 
DIDS. 17 β-estradiol potentiation of thapsigargin-stimulated Cl¯ secretion does not change when 
T84 monolayers are treated either with NPPB or DIDS. These observations prove that 17 β-
estradiol potentiation of Ca2+-stimulated Cl¯ secretion does not involve activation of Cl¯ channels 
other than CFTR in T84 cells. 
The opening and closing of the CFTR Cl¯ channel is regulated by the balance of kinase 
and phosphatase activity within the cell and by cellular ATP levels. Activation of cAMP-
dependent protein kinase (PKA) causes phosphorylation of multiple serine residues within the 
regulatory domain of CFTR (Figure 23). Once the regulatory domain is phosphorylated, gating 
of the CFTR channel is regulated by a cycle of ATP hydrolysis at the nucleotide-binding 
domains. Protein phosphatases dephosphorylate the regulatory domain to return the CFTR 
channel to its quiescent state (Sheppard and Welsh 1999).  
H89, a specific and potent inhibitor of PKA, completely blocked 17 β-estradiol 
potentiation of Ca2+-stimulated chloride secretion, proving that the the 17 β-estradiol potentiation 
of Ca2+-stimulated Cl¯ secretion requires active CFTR Cl¯ channels. Future experiments should 
be designed to measure the cAMP levels in 17 β-estradiol treated T84 monolayers to determine 
whether 17 β-estradiol causes an increase in cAMP in T84 cells. 
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Figure 23  Model Showing Proposed Domain Structure of Cystic Fibrosis Transmembrane  
Regulator (CFTR). MSD, membrane-spanning domain; NBD, nucleotide-binding domain; R, 
regulatory domain; PKA, cAMP-dependent protein kinase (Sheppard and Welsh 1999).     
 
 
 To test whether 17 β-estradiol increased the activity of Ca2-activated K+ channels in the 
basolateral membrane of T84 monolayers, the apical membrane was permeabilized with nystatin, 
and the spontaneous sodium current blocked by the addition of ouabain. Under these conditions, 
17 β-estradiol did not increase the thapsigargin-stimulated IK, indicating that the activation of 
basolateral membrane K+ is not the target for the nongenomic action of 17 β-estradiol. Future 
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experiments should be designed to study the apical CFTR activity by permeabilization of the 
basolateral membrane.  
There are many references in the literature to suggest that 17 β-estradiol can stimulate the 
activity of PKA, PKC, and/or MAP kinase pathways. In the rat brain 17 β-estradiol acts on 
estrogen receptors locally within the hippocampus through a nongenomic mechanism to activate 
PKA and PKC, to phosphorylate the serotonin-1A receptors and uncouple them from their G 
proteins (Mize and Alper 2002). In intracellular recordings from female guinea pig hypothalamic 
slices it has been shown that 17 β-estradiol rapidly activates both PKA and PKC to cause 
heterologous desensitization of mu-opioids and GABA(B) receptors, which has the potential to 
alter synaptic transmission in many regions of the central nervous system (Kelly and others 
1999). 17 β-estradiol increases oviductal protein phosphorylation in rats by a nongenomic action 
mediated by PKA and PKC (Orihuela and Croxatto 2001). In the human hepatoma HepG2 cell 
line 17 β-estradiol has been found to rapidly activate PKCα translocation and ERK-2/mitogen-
activated protein kinase phosphorylation (Marino and others 2002). The estrogen receptor 
antagonist ICI 182780 and the MEK inhibitor PD 98059 prevented 17 β-estradiol-mediated-
neuroprotection indicating that activation of the MAP kinase pathway is an important part of the 
neuroprotective mechanism (Mize and others 2003). In primary cultured rabbit kidney proximal 
tubule cells 17 β-estradiol-BSA conjugate rapidly stimulates Ca2+ uptake, which is mediated by 
cAMP and PKC pathways (Han and others 2000). 17 β-estradiol causes a dose-dependent 
increase in PKCα in resting zone and growth zone chondrocytes in female rats (Sylvia and others 
1998). In a human endometrial cell line (RL95-2) 17 β-estradiol stimulates capacitance Ca2+ 
entry through store-operated calcium channels via a PKC-sensitive pathway (Perret and others 
2001). In the female rat distal colonic crypts the 17 β-estradiol induced increase in intracellular 
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Ca2+ involves activation of PKCδ (Doolan and Harvey 2003), and inhibition of forskolin-induced 
Cl¯ secretion is dependent on PKC activation (Condliffe and others 2001). Using the PKC 
inhibitor BIM (bisindolylmaleimide) and the MEK inhibitor PD 98059, this study has shown that 
the 17 β-estradiol potentiation of Ca2+-stimulated Cl¯ secretion is not mediated through the PKC 
or MEK pathways. 
   The idea that calcium might enter cells through a capacitative store-operated mechanism 
was first introduced by Jim Putney almost two decades ago (Putney 1986). The hypothesis was 
that calcium entry is regulated by the state of filling of the calcium stores. By analogy with a 
capacitor in an electrical circuit, the calcium stores prevent entry when they are charged up but 
immediately begin to promote entry as soon as stored calcium is discharged. This capacitative 
entry mechanism is present in many excitable and nonexcitable cells (Putney 1986; Putney 1990; 
Berridge 1995; Putney 2003). Capacitative calcium entry can be switched on by a great variety 
of stimuli such as the calcium-mobilizing second messenger inositol 1,4,5-trisphosphate 
(Petersen and Berridge 1994; DeLisle and others 1995; Birnbaumer and others 2000; 
Raeymaekers and others 2002), the calcium ionophore ionomycin (Morgan and Jacob 1994), and 
inhibitors of the endoplasmic reticulum pumps such as thapsigargin (Petersen and Berridge 1994; 
Denys and others 2004). There is no consensus on precisely how store-operated calcium entry is 
controlled in electrically nonexcitable cells (Elliott 2001; Smani and others 2004). 
It has been reported that in T84 monolayers, a capacitative store-operated calcium 
pathway is located in the basolateral membrane (Kerstan and others 1999). In the human 
endometrial cell line (RL95-2) 17 β-estradiol-induced Ca2+ influx is significantly increased by 
the depletion of intracellular stores by thapsigargin and decreased by chelerythrine chloride, an 
inhibitor of protein kinase C. These data indicate a nongenomic action of 17 β-estradiol to 
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stimulate capacitative Ca2+ entry through store-operated calcium channels (Perret and others 
2001). This study shows that the17 β-estradiol potentiation of thapsigargin-stimulated Cl¯ 
secretion is dependent on the presence of extracellular Ca2+. 17 β-estradiol potentiation of 
thapsigargin-stimulated ISC is blocked in T84 monolayers bathed in low Ca2+ or zero Ca2+ 
Ringer. This suggests that 17 β-estradiol opens up additional store-operated calcium channels 
and increases Ca2+ entry in thapsigargin-stimulated monolayers by a rapid nongenomic 
mechanism. Thapsigargin increases intracellular calcium by inhibiting Ca2+-ATPase activity of 
the endoplasmic reticulum. 17 β-estradiol might act by releasing additional Ca2+ from 
intracellular stores in the presence of thapsigargin, providing the stimulus for opening of store-
operated calcium channels. Elevation in intracellular Ca2+ opens additional basolateral potassium 
channels, providing additional driving force for Cl¯ exit through constitutively open CFTR 
channels in the apical membrane. However, 17 β-estradiol potentiation of carbachol-stimulated 
ISC did not change in monolayers bathed in low Ca2+. This is probably due to the difference in the 
mechanism by which carbachol raises intracellular Ca2+. Carbachol binds to a basolateral G 
protein-linked muscarinic receptor, and yields calcium-mobilizing messenger Ins(1,4,5)P3 via 
activation of phospholipase C and phosphatidylinositol hydrolysis. In 17 β-estradiol treated 
monolayers, carbachol might not be producing enough Ins(1,4,5)P3 to cause sufficient depletion 
of intracellular Ca2+ stores necessary to stimulate the opening of store-operated calcium 
channels. 
Contrary to expectations, T84 cell suspensions treated with 17 β-estradiol showed 
significant lower peak [Ca2+]i upon thapsigargin-stimulation compared to controls. To enhance 
cell viability, T84 cultures were trypsinized the day before each experiment and maintained 
overnight in suspension. Preincubation of T84 cells with 17 β-estradiol alone (unless stimulated 
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with thapsigargin) did not change [Ca2+]i. The thapsigargin-stimulated [Ca2+]i in 17 β-estradiol-
treated cells returned closer to basal level at the end of the experiment compared to untreated 
cells.  
Cell polarity, a distinguishing feature of epithelial cells, is a prerequisite to the 
transepithelial transport of solutes (McRoberts and Barrett 1989). T84 cells, when grown on 
semipermeable supports develop tight junctions, form polarized monolayers of cells with distinct 
apical and basolateral membranes. In suspension, these cells lose their polarity, their tight 
junctions are disrupted; they form rounded cells, and hence behave differently from T84 cells 
grown in a monolayer. My experiments with T84 cell suspensions suggest that 17 β-estradiol 
causes different and distinct nongenomic effects in cell suspension. These differences are due to 
loss of polarity in suspension and subsequent rearrangement of the cytoskeleton. Remnants of 
trypsin in cell suspension might make the cells fragile and affect the rapid responses of 17 β-
estradiol. Future experiments should be designed to measure [Ca2+]i in 17 β-estradiol treated T84 
monolayers.        
17 β-estradiol inhibits cAMP-stimulated chloride secretion by acting as a CFTR channel 
blocker and binding directly to CFTR (Singh and others 2000), but potentiates Ca2+-stimulated 
chloride secretion by enhancing the calcium sensitivity of CFTR activation. 17 β-estradiol 
increases monolayer electrical conductance but does not increase the activity of calcium-
activated potassium channels or any calcium-activated apical chloride channels. 17 β-estradiol 
potentiation is not mediated via the PKC or MEK pathways and does not require the classical 
nuclear estrogen receptors. 17 β-estradiol might act by opening additional basolateral store-
operated calcium channels or opening additional apical CFTR channels. Future experiments 
should use 17 β-estradiol conjugated to bovine serum albumin to determine the role of any 
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unidentified membrane receptor in 17 β-estradiol potentiation. Better understanding of the 
nongenomic actions of estrogens on epithelial Cl¯ secretion will open new perspectives in the 
pharmacological treatment of pathological conditions like cystic fibrosis and secretory diarrhea. 
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